Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects
Clinical trial NCT04570267 · COMPLETED
Trial details
- NCT number
- NCT04570267
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2021-11-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.